← Evidence map

TrialBMC cancer2014

Wnt modulates MCL1 to control cell survival in triple negative breast cancer.

Lixin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24564888